The purpose of this study is to determine whether treatment with Toprol-XL for 12 months in
asymptomatic heart failure subjects will improve their heart structure and thus prevent the
progression to symptomatic disease.
COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
Terminated
GlaxoSmithKline
Phase 3
2005-07-01
This study was designed to determine whether COREG MR is more effective than TOPROL-XL in
reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood
pressure and microalbuminuria.
Reducing Total Cardiovascular Risk in an Urban Community
Completed
National Heart, Lung, and Blood Institute (NHLBI)
Phase 4
2006-05-01
PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON
FAMILY HEALTH CENTER.
The purpose of this study is to compare the clinical effectiveness and cost effectiveness of
two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with
a less intensive (LI) intervention - in African American, and white low-income patients with
known excessive cardiovascular disease risk.
Reducing Total Cardiovascular Risk in an Urban Community
Completed
Johns Hopkins University
Phase 4
2006-05-01
PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON
FAMILY HEALTH CENTER.
The purpose of this study is to compare the clinical effectiveness and cost effectiveness of
two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with
a less intensive (LI) intervention - in African American, and white low-income patients with
known excessive cardiovascular disease risk.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.